| PERCOCET ® (Oxycodone and Acetaminophen Tablets, USP) CII Rx only Revised: August 2026 | Product name | SpecGx LLC | 2026-10-02 |
| These highlights do not include all the information needed to use REXTOVY™ Nasal Spray safely and effectively. See full prescribing information for REXTOVY™ Nasal Spray. REXTOVY™ (naloxone hydrochloride) Nasal Spray Initial U.S. Approval: 1971 | Product name | International Medication Systems, Ltd. | 2026-09-30 |
| Human Prescription Drug Label OXYCODONE AND ACETAMINOPHEN - oxycodone and acetaminophen tablet | Product name | Asclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM | 2026-09-23 |
| PERCOCET ® (Oxycodone and Acetaminophen Tablets, USP) CII Rx only Revised: August 2026 | Product name | SpecGx LLC | 2026-09-23 |
| These highlights do not include all the information needed to use OXYCODONE HYDROCHLORIDE ORAL SOLUTION safely and effectively. See full prescribing information for OXYCODONE HYDROCHLORIDE ORAL SOLUTION. OXYCODONE HYDROCHLORIDE oral solution, CII Initial U.S. Approval: 1950 | Product name | SpecGx LLC | 2026-09-15 |
| These highlights do not include all the information needed to use OXYCODONE HYDROCHLORIDE CAPSULES safely and effectively. See full prescribing information for OXYCODONE HYDROCHLORIDE CAPSULES. Oxycodone Hydrochloride capsules for oral use, CII Initial U.S. Approval: 1950 | Product name | KVK-TECH, INC. | AVANTHI INC. | 2026-09-09 |
| Naloxone Hydrochloride Nasal Spray | Product name | Amneal Pharmaceuticals LLC | 2026-08-25 |
| NARCAN® Naloxone HCl Nasal Spray 4 mg Drug Facts | Product name | Emergent Devices Inc. | 2026-08-17 |
| These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | Product name | REMEDYREPACK INC. | 2026-08-17 |
| These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | Product name | REMEDYREPACK INC. | 2026-08-17 |
| Oxycodone and Acetaminophen Tablets, USP CII | Product name | St. Mary's Medical Park Pharmacy | 2026-08-14 |
| These highlights do not include all the information needed to use OXYCODONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for OXYCODONE HYDROCHLORIDE TABLETS. OXYCODONE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1950 | Product name | SpecGx LLC | 2026-08-07 |
| Nalocet | Product name | Forte Bio-Pharma LLC | 2026-08-06 |
| These highlights do not include all the information needed to use OXYCODONE HYDROCHLORIDE ORAL SOLUTION safely and effectively. See full prescribing information for OXYCODONE HYDROCHLORIDE ORAL SOLUTION. OXYCODONE Hydrochloride oral solution USP, for oral use CII Initial U.S. Approval: 1950 | Product name | KVK-Tech, Inc. | ABHAI, LLC. | 2026-07-29 |
| Oxycodone and Acetaminophen Tablets | Product name | FH2 Pharma LLC | 2026-07-28 |
| PERCOCET ® (Oxycodone and Acetaminophen Tablets, USP) CII Rx only Revised: December 2025 | Product name | SpecGx LLC | 2026-07-28 |
| PERCOCET ® (Oxycodone and Acetaminophen Tablets, USP) CII Rx only Revised: December 2025 | Product name | Endo USA, Inc. | 2026-07-28 |
| Prolate (Oxycodone Hydrochloride and Acetaminophen Oral Solution) | Product name | Forte Bio-Pharma LLC | 2026-07-28 |
| Oxycodone and Acetaminophen Tablets USP CII 5 mg*/325 mg, 7.5 mg*/325 mg and 10 mg*/325 mg Revised: JANUARY 2026 | Product name | SpecGx LLC | 2026-07-27 |
| These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | Product name | Hikma Pharmaceuticals USA Inc. | West-Ward Columbus Inc. | 2026-07-26 |
| These highlights do not include all the information needed to use OXYCODONE HCl TABLETS safely and effectively. See full prescribing information for OXYCODONE HCl TABLETS. OXYCODONE HCl tablets, for oral use, CII Initial U.S. Approval: 1950 | Product name | Major Pharmaceuticals | 2026-07-23 |
| Oxycodone and Acetaminophen Tablets, USP CII | Product name | St. Mary's Medical Park Pharmacy | 2026-07-14 |
| These highlights do not include all the information needed to use OXYCODONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for OXYCODONE HYDROCHLORIDE TABLETS. OXYCODONE HYDROCHLORIDE tablets USP, for oral use, CII Initial U.S. Approval: 1950 | Product name | St. Mary's Medical Park Pharmacy | 2026-07-14 |
| These highlights do not include all the information needed to use OXYCODONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for OXYCODONE HYDROCHLORIDE TABLETS. Oxycodone Hydrochloride Tablets USP, for oral use, CII Initial U.S. Approval: 1950 | Product name | Bryant Ranch Prepack | 2026-07-14 |
| Human Prescription Drug Label OXYCODONE AND ACETAMINOPHEN - oxycodone and acetaminophen tablet | Product name | Major Pharmaceuticals | 2026-07-02 |
| Naloxone Hydrochloride Injection, USP | Product name | Civica, Inc. | 2026-06-30 |
| OXYCODONE AND ACETAMINOPHEN TABLETS, USP 5 mg*/325 mg, 7.5 mg*/325 mg, 10 mg*/325 mg CII | Product name | Bryant Ranch Prepack | 2026-06-30 |
| These highlights do not include all the information needed to use OXYCODONE HYDROCHLORIDE ORAL SOLUTION safely and effectively. See full prescribing information for OXYCODONE HYDROCHLORIDE ORAL SOLUTION. Oxycodone Hydrochloride oral solution CII Initial U.S. Approval: 1950 | Product name | Eywa Pharma Inc | WES Pharma Inc. | 2026-06-30 |
| Human Prescription Drug Label OXYCODONE AND ACETAMINOPHEN - oxycodone and acetaminophen tablet | Product name | Bryant Ranch Prepack | 2026-06-29 |
| These highlights do not include all the information needed to use OXYCODONE HYDROCHLORIDE Tablets, USP safely and effectively. See full prescribing information for Oxycodone Hydrochloride Tablets, USP. OXYCODONE HYDROCHLORIDE Tablets, USP, for oral use, CII Initial U.S. Approval: 1950 | Product name | Bryant Ranch Prepack | 2026-06-29 |
| Oxycodone and Acetaminophen Tablets, USP CII | Product name | St. Mary's Medical Park Pharmacy | 2026-06-25 |
| OXYCODONE AND ACETAMINOPHEN TABLETS, USP 5 mg*/325 mg, 7.5 mg*/325 mg, 10 mg*/325 mg CII | Product name | Bryant Ranch Prepack | 2026-06-24 |
| OXYCODONE AND ACETAMINOPHEN TABLETS, USP 5 mg*/325 mg, 7.5 mg*/325 mg, 10 mg*/325 mg CII | Product name | Bryant Ranch Prepack | 2026-06-24 |
| These highlights do not include all the information needed to use OXYCONTIN ® safely and effectively. See full prescribing information for OXYCONTIN. OXYCONTIN ® (oxycodone hydrochloride) extended-release tablets, for oral use, CII Initial U.S. Approval: 1950 | Product name | Knoa Pharma LLC | Knoa Pharmaceuticals L.P. | AndersonBrecon Inc. | Noramco | Aphena Pharma Solutions | Sharp Packaging Services, LLC | 2026-06-24 |
| These highlights do not include all the information needed to use OXYCODONE HCl TABLETS safely and effectively. See full prescribing information for OXYCODONE HCl TABLETS. OXYCODONE HCl tablets, for oral use, CII Initial U.S. Approval: 1950 | Product name | Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals of New York, LLC | 2026-06-23 |
| OXYCODONE AND ACETAMINOPHEN TABLETS, USP 5 mg*/325 mg, 7.5 mg*/325 mg, 10 mg*/325 mg CII | Product name | Bryant Ranch Prepack | 2026-06-19 |
| Pentazocine and Naloxone Tablets , USP CIV | Product name | Actavis Pharma, Inc. | 2026-06-19 |
| These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, CIII Initial U.S. Approval: 2002 | Product name | Bryant Ranch Prepack | 2026-06-18 |
| These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE sublingual tablets, USP safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE sublingual tablets, USP. BUPRENORPHINE and NALOXONE sublingual tablets, USP, CIII Initial U.S. Approval: 2002 | Product name | Bryant Ranch Prepack | 2026-06-16 |
| These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE sublingual tablets, USP safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE sublingual tablets, USP. BUPRENORPHINE and NALOXONE sublingual tablets, USP, CIII Initial U.S. Approval: 2002 | Product name | Bryant Ranch Prepack | 2026-06-16 |
| These highlights do not include all the information needed to use OXYCODONE HYDROCHLORIDE ORAL SOLUTION safely and effectively. See full prescribing information for OXYCODONE HYDROCHLORIDE ORAL SOLUTION. OXYCODONE HYDROCHLORIDE Oral Solution, CII Initial U.S. Approval: 1950 | Product name | Bryant Ranch Prepack | 2026-06-16 |
| These highlights do not include all the information needed to use OXYCODONE HYDROCHLORIDE Tablets, USP safely and effectively. See full prescribing information for Oxycodone Hydrochloride Tablets, USP. OXYCODONE HYDROCHLORIDE Tablets, USP, for oral use, CII Initial U.S. Approval: 1950 | Product name | Bryant Ranch Prepack | 2026-06-16 |
| OXYCODONE AND ACETAMINOPHEN TABLETS, USP 5 mg*/325 mg, 7.5 mg*/325 mg, 10 mg*/325 mg CII | Product name | St. Mary's Medical Park Pharmacy | 2026-06-15 |
| Oxycodone and Acetaminophen Tablets, USP CII | Product name | St. Mary's Medical Park Pharmacy | 2026-06-15 |
| Oxycodone and Acetaminophen Tablets, USP CII Rx Only | Product name | St. Mary's Medical Park Pharmacy | 2026-06-15 |
| These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE sublingual tablets, USP safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE sublingual tablets, USP. BUPRENORPHINE and NALOXONE sublingual tablets, USP, CIII Initial U.S. Approval: 2002 | Product name | Bryant Ranch Prepack | 2026-06-12 |
| These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, CIII Initial U.S. Approval: 2002 | Product name | Bryant Ranch Prepack | 2026-06-11 |
| These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS . BUPRENORPHINE AND NALOXONE sublingual tablets, for sublingual administration, CIII Initial U.S. Approval: 2002 | Product name | SpecGx LLC | 2026-06-10 |
| These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | Product name | REMEDYREPACK INC. | 2026-06-10 |
| These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | Product name | REMEDYREPACK INC. | 2026-06-09 |
| These highlights do not include all the information needed to use B UPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for B UPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE AND NALOXONE sublingual tablets, CIII Initial U.S. Approval: 2002 | Product name | Bryant Ranch Prepack | 2026-06-08 |
| These highlights do not include all the information needed to use OXYCODONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for OXYCODONE HYDROCHLORIDE TABLETS. Initial U.S. Approval: 1950 | Product name | KVK-TECH,INC | KVK-TECH, INC | 2026-06-04 |
| Nalocet | Product name | Forte Bio-Pharma LLC | 2026-06-03 |
| Naloxone Hydrochloride Injection, USP USP type-I clear tubular glass Vial, Opioid Antagonist Protect from light by retaining in the carton until ready for use. Discard unused portion. Rx only | Product name | A-S Medication Solutions | 2026-06-03 |
| These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE sublingual tablets, USP safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE sublingual tablets, USP. BUPRENORPHINE and NALOXONE sublingual tablets, USP, CIII Initial U.S. Approval: 2002 | Product name | Bryant Ranch Prepack | 2026-06-03 |
| These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE sublingual tablets, USP safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE sublingual tablets, USP. BUPRENORPHINE and NALOXONE sublingual tablets, USP, CIII Initial U.S. Approval: 2002 | Product name | Bryant Ranch Prepack | 2026-06-03 |
| These highlights do not include all the information needed to use OXYCODONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for OXYCODONE HYDROCHLORIDE TABLETS. OXYCODONE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1950 | Product name | Redpharm Drug | 2026-05-30 |
| These highlights do not include all the information needed to use OXYCODONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for OXYCODONE HYDROCHLORIDE TABLETS. OXYCODONE HYDROCHLORIDE tablets, USP, for oral use, CII Initial U.S. Approval: 1950 | Product name | Bryant Ranch Prepack | 2026-05-29 |
| Human Prescription Drug Label OXYCODONE AND ACETAMINOPHEN - oxycodone and acetaminophen tablet | Product name | Eywa Pharma Inc | WES Pharma Inc. | 2026-05-28 |
| NALOXONE HYDROCHLORIDE | Product name | Hospira, Inc. | 2026-05-27 |
| These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE sublingual tablets, USP safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE sublingual tablets, USP. BUPRENORPHINE and NALOXONE sublingual tablets, USP, CIII Initial U.S. Approval: 2002 | Product name | REMEDYREPACK INC. | 2026-05-22 |
| These highlights do not include all the information needed to use OXYCODONE HCl TABLETS safely and effectively. See full prescribing information for OXYCODONE HCl TABLETS. OXYCODONE HCl tablets, for oral use, CII Initial U.S. Approval: 1950 | Product name | Redpharm Drug | 2026-05-21 |
| Prolate ® (Oxycodone and Acetaminophen Tablets, USP) | Product name | Forte Bio-Pharma LLC | 2026-05-19 |
| These highlights do not include all the information needed to use OXYCODONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for OXYCODONE HYDROCHLORIDE TABLETS. OXYCODONE HYDROCHLORIDE tablets USP, for oral use, CII Initial U.S. Approval: 1950 | Product name | ST. MARY'S MEDICAL PARK PHARMACY | 2026-05-19 |
| These highlights do not include all the information needed to use OXYCODONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for OXYCODONE HYDROCHLORIDE TABLETS. OXYCODONE HYDROCHLORIDE tablets USP, for oral use, CII Initial U.S. Approval: 1950 | Product name | ST. MARY'S MEDICAL PARK PHARMACY | 2026-05-19 |
| OXYCODONE AND ACETAMINOPHEN TABLETS, USP 5 mg*/325 mg, 7.5 mg*/325 mg, 10 mg*/325 mg CII | Product name | Bryant Ranch Prepack | 2026-05-15 |
| Oxycodone and Acetaminophen Tablets, USP CII Rx Only | Product name | St. Mary's Medical Park Pharmacy | 2026-05-15 |
| These highlights do not include all the information needed to use OXYCODONE HCl EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for OXYCODONE HCl EXTENDED-RELEASE TABLETS. OXYCODONE HCl EXTENDED-RELEASE TABLETS, for oral use, CII Initial U.S. Approval: 1950 | Product name | Amneal Pharmaceuticals of New York LLC | Anderson Packaging, Inc | Purdue Pharmaceuticals L.P. | Sharp Packaging Solutions | 2026-05-15 |
| OXYCODONE AND ACETAMINOPHEN TABLETS, USP 5 mg*/325 mg, 7.5 mg*/325 mg, 10 mg*/325 mg CII | Product name | Bryant Ranch Prepack | 2026-05-14 |
| These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS . BUPRENORPHINE AND NALOXONE sublingual tablets, CIII Initial U.S. Approval: 2002 | Product name | Bryant Ranch Prepack | 2026-05-14 |
| These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | Product name | Bryant Ranch Prepack | 2026-05-14 |
| Meitheal Pharmaceuticals Inc. | Sterinova Inc. human prescription drug label | Product name | Meitheal Pharmaceuticals Inc. | Sterinova Inc. | 2026-05-13 |
| Human Prescription Drug Label OXYCODONE AND ACETAMINOPHEN - oxycodone and acetaminophen tablet | Product name | Major Pharmaceuticals | 2026-05-13 |
| These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | Product name | Bryant Ranch Prepack | 2026-05-13 |
| OXYCODONE AND ACETAMINOPHEN TABLETS, USP 5 mg*/325 mg, 7.5 mg*/325 mg, 10 mg*/325 mg CII | Product name | Rhodes Pharmaceuticals LLC | Knoa Pharmaceuticals LLC | 2026-05-06 |
| These highlights do not include all the information needed to use OXYCODONE HYDROCHLORIDE Tablets, USP safely and effectively. See full prescribing information for Oxycodone Hydrochloride Tablets, USP. OXYCODONE HYDROCHLORIDE Tablets, USP, for oral use, CII Initial U.S. Approval: 1950 | Product name | Rhodes Pharmaceuticals LLC | Knoa Pharmaceuticals LLC | 2026-05-06 |
| Human Prescription Drug Label OXYCODONE AND ACETAMINOPHEN - oxycodone and acetaminophen tablet | Product name | Eywa Pharma Inc | WES Pharma Inc. | 2026-05-05 |
| Naloxone Hydrochloride Injection, USP USP type-I clear tubular glass Vial, Opioid Antagonist Protect from light by retaining in the carton until ready for use. Discard unused portion. Rx only | Product name | Somerset Therapeutics, LLC | Somerset Therapeutics Private Limited | 2026-05-05 |
| Oxycodone and Acetaminophen Tablets, USP CII Rx only Rev.: 10/2025 | Product name | KVK-Tech, Inc. | ABHAI, LLC. | 2026-05-04 |
| These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE sublingual tablets, USP safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE sublingual tablets, USP. BUPRENORPHINE and NALOXONE sublingual tablets, USP, CIII Initial U.S. Approval: 2002 | Product name | Rhodes Pharmaceuticals LLC | Knoa Pharmaceuticals LLC | Halo Pharmaceutical Inc. | 2026-05-01 |
| These highlights do not include all the information needed to use OXYCONTIN ® safely and effectively. See full prescribing information for OXYCONTIN. OXYCONTIN ® (oxycodone hydrochloride) extended-release tablets, for oral use, CII Initial U.S. Approval: 1950 | Product name | Knoa Pharma LLC | Knoa Pharmaceuticals L.P. | AndersonBrecon Inc. | Noramco | Aphena Pharma Solutions | Sharp Packaging Services, LLC | 2026-05-01 |
| Oxycodone Hydrochloride and Acetaminophen Oral Solution | Product name | FH2 Pharma LLC | 2026-04-27 |
| BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | Product name | Golden State Medical Supply, Inc. | 2026-04-24 |
| NARCAN® Naloxone HCl Nasal Spray 4 mg Drug Facts | Product name | Sportpharm LLC | 2026-04-24 |
| These highlights do not include all the information needed to use ROXICODONE ® safely and effectively. See full prescribing information for ROXICODONE. ROXICODONE (oxycodone HCl) tablets, for oral use, CII Initial U.S. Approval: 1950 | Product name | SpecGx LLC | 2026-04-24 |
| Nalocet | Product name | Forte Bio-Pharma LLC | 2026-04-23 |
| NARCAN® Naloxone HCl Nasal Spray 4 mg Drug Facts | Product name | Emergent Devices Inc. | 2026-04-22 |
| OXYCODONE AND ACETAMINOPHEN TABLETS, USP 5 mg*/325 mg, 7.5 mg*/325 mg, 10 mg*/325 mg CII | Product name | Bryant Ranch Prepack | 2026-04-22 |
| These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM. BUPRENORPHINE and NALOXONE sublingual film, for sublingual or buccal use, CIII Initial U.S. Approval: 2002 | Product name | Redpharm Drug | 2026-04-22 |
| These highlights do not include all the information needed to use OXYCODONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for OXYCODONE HYDROCHLORIDE TABLETS. OXYCODONE HYDROCHLORIDE tablets, USP, for oral use, CII Initial U.S. Approval: 1950 | Product name | Bryant Ranch Prepack | 2026-04-22 |
| These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS . BUPRENORPHINE AND NALOXONE sublingual tablets, CIII Initial U.S. Approval: 2002 | Product name | Unit Dose Solutions, Inc. | 2026-04-16 |
| These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE sublingual tablets, USP safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE sublingual tablets, USP. BUPRENORPHINE and NALOXONE sublingual tablets, USP, CIII Initial U.S. Approval: 2002 | Product name | Bryant Ranch Prepack | 2026-04-16 |
| These highlights do not include all the information needed to use OXYCODONE HYDROCHLORIDE ORAL SOLUTION safely and effectively. See full prescribing information for OXYCODONE HYDROCHLORIDE ORAL SOLUTION. Oxycodone Hydrochloride oral solution CII Initial U.S. Approval: 1950 | Product name | Genus Lifesciences Inc. | 2026-04-16 |
| Oxycodone and Acetaminophen Tablets, USP CII Rx Only | Product name | ST. MARY'S MEDICAL PARK PHARMACY | 2026-04-15 |
| OXYCODONE AND ACETAMINOPHEN TABLETS, USP 5 mg*/325 mg, 7.5 mg*/325 mg, 10 mg*/325 mg CII | Product name | Bryant Ranch Prepack | 2026-04-14 |
| These highlights do not include all the information needed to use OXYCODONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for OXYCODONE HYDROCHLORIDE TABLETS. OXYCODONE HYDROCHLORIDE tablets USP, for oral use, CII Initial U.S. Approval: 1950 | Product name | ST. MARY'S MEDICAL PARK PHARMACY | 2026-04-14 |
| These highlights do not include all the information needed to use OXYCODONE HYDROCHLORIDE Tablets, USP safely and effectively. See full prescribing information for Oxycodone Hydrochloride Tablets, USP. OXYCODONE HYDROCHLORIDE Tablets, USP, for oral use, CII Initial U.S. Approval: 1950 | Product name | Bryant Ranch Prepack | 2026-04-14 |
| Human Prescription Drug Label OXYCODONE AND ACETAMINOPHEN - oxycodone and acetaminophen tablet | Product name | Bryant Ranch Prepack | 2026-04-13 |
| OXYCODONE AND ACETAMINOPHEN TABLETS, USP 5 mg*/325 mg, 7.5 mg*/325 mg, 10 mg*/325 mg CII | Product name | Rhodes Pharmaceuticals L.P. | Purdue Pharmaceuticals L.P. | 2026-04-10 |
| Oxycodone and Acetaminophen Tablets, USP CII | Product name | Elite Laboratories, Inc. | 2026-04-09 |
| These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE sublingual tablets, USP safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE sublingual tablets, USP. BUPRENORPHINE and NALOXONE sublingual tablets, USP, CIII Initial U.S. Approval: 2002 | Product name | REMEDYREPACK INC. | 2026-04-08 |
| These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM. BUPRENORPHINE and NALOXONE sublingual film, for sublingual or buccal use, CIII Initial U.S. Approval: 2002 | Product name | Aveva Drug Delivery Systems Inc. | DifGen Pharmaceuticals LLC | 2026-04-07 |
| These highlights do not include all the information needed to use OXYCODONE HYDROCHLORIDE Tablets, USP safely and effectively. See full prescribing information for Oxycodone Hydrochloride Tablets, USP. OXYCODONE HYDROCHLORIDE Tablets, USP, for oral use, CII Initial U.S. Approval: 1950 | Product name | Bryant Ranch Prepack | 2026-04-07 |
| These highlights do not include all the information needed to use OXYCODONE HYDROCHLORIDE Tablets, USP safely and effectively. See full prescribing information for Oxycodone Hydrochloride Tablets, USP. OXYCODONE HYDROCHLORIDE Tablets, USP, for oral use, CII Initial U.S. Approval: 1950 | Product name | Bryant Ranch Prepack | 2026-04-07 |
| These highlights do not include all the information needed to use OXYCODONE HYDROCHLORIDE Tablets, USP safely and effectively. See full prescribing information for Oxycodone Hydrochloride Tablets, USP. OXYCODONE HYDROCHLORIDE Tablets, USP, for oral use, CII Initial U.S. Approval: 1950 | Product name | Bryant Ranch Prepack | 2026-04-07 |
| These highlights do not include all the information needed to use OXYCODONE HYDROCHLORIDE Tablets, USP safely and effectively. See full prescribing information for Oxycodone Hydrochloride Tablets, USP. OXYCODONE HYDROCHLORIDE Tablets, USP, for oral use, CII Initial U.S. Approval: 1950 | Product name | Bryant Ranch Prepack | 2026-04-07 |
| OXYCODONE AND ACETAMINOPHEN TABLETS, USP 5 mg*/325 mg, 7.5 mg*/325 mg, 10 mg*/325 mg CII | Product name | Bryant Ranch Prepack | 2026-04-03 |
| These highlights do not include all the information needed to use B UPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for B UPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE AND NALOXONE sublingual tablets, CIII Initial U.S. Approval: 2002 | Product name | Bryant Ranch Prepack | 2026-04-03 |
| These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE sublingual tablets, USP safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE sublingual tablets, USP. BUPRENORPHINE and NALOXONE sublingual tablets, USP, CIII Initial U.S. Approval: 2002 | Product name | Bryant Ranch Prepack | 2026-04-03 |
| These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE sublingual tablets, USP safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE sublingual tablets, USP. BUPRENORPHINE and NALOXONE sublingual tablets, USP, CIII Initial U.S. Approval: 2002 | Product name | Bryant Ranch Prepack | 2026-04-03 |
| Naloxone HCl Nasal Spray Drug Facts | Product name | BluePoint Laboratories | Padagis Israel Pharmaceuticals Ltd | 2026-04-02 |
| These highlights do not include all the information needed to use OXYCODONE HYDROCHLORIDE ORAL SOLUTION safely and effectively. See full prescribing information for OXYCODONE HYDROCHLORIDE ORAL SOLUTION. OXYCODONE HYDROCHLORIDE Oral Solution, CII Initial U.S. Approval: 1950 | Product name | Bryant Ranch Prepack | 2026-03-31 |
| These highlights do not include all the information needed to use OXYCODONE HYDROCHLORIDE Tablets, USP safely and effectively. See full prescribing information for Oxycodone Hydrochloride Tablets, USP. OXYCODONE HYDROCHLORIDE Tablets, USP, for oral use, CII Initial U.S. Approval: 1950 | Product name | Bryant Ranch Prepack | 2026-03-27 |
| These highlights do not include all the information needed to use OXYCONTIN ® safely and effectively. See full prescribing information for OXYCONTIN. OXYCONTIN ® (oxycodone hydrochloride) extended-release tablets, for oral use, CII Initial U.S. Approval: 1950 | Product name | Knoa Pharma LLC | Knoa Pharmaceuticals L.P. | AndersonBrecon Inc. | Noramco | Aphena Pharma Solutions | Sharp Packaging Services, LLC | 2026-03-26 |
| Oxycodone and Acetaminophen Tablets, USP CII | Product name | ST. MARY'S MEDICAL PARK PHARMACY | 2026-03-25 |
| These highlights do not include all the information needed to use OXYCODONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for OXYCODONE HYDROCHLORIDE TABLETS. OXYCODONE HYDROCHLORIDE tablets, USP, for oral use, CII Initial U.S. Approval: 1950 | Product name | Bryant Ranch Prepack | 2026-03-24 |
| These highlights do not include all the information needed to use OXYCODONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for OXYCODONE HYDROCHLORIDE TABLETS. OXYCODONE HYDROCHLORIDE tablets, USP, for oral use, CII Initial U.S. Approval: 1950 | Product name | Bryant Ranch Prepack | 2026-03-24 |
| These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM. BUPRENORPHINE and NALOXONE sublingual film, for sublingual or buccal use, CIII Initial U.S. Approval: 2002 | Product name | INGENUS PHARMACEUTICALS, LLC | DifGen Pharmaceuticals LLC | Aveva Drug Delivery Systems, Inc | 2026-03-23 |
| HF Acquisition Co. LLC. DBA HealthFirst human prescription drug label | Product name | HF Acquisition Co. LLC. DBA HealthFirst | 2026-03-19 |
| Nalocet | Product name | Forte Bio-Pharma LLC | 2026-03-16 |